Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9 Melanoma 4 Neoplasms 3 Multiple Myeloma 3 Skin Neoplasms 2 Polycystic Ovary Syndrome 2 Venous Thromboembolism 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Skin Toxicity 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Renal Insufficiency 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Obesity 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Meningioma 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Leukemia 1 Inflammation 1

Interventions

Docetaxel 137 Prednisone 120 Abiraterone Acetate 91 Leuprolide 86 enzalutamide 84 Radiotherapy 59 bicalutamide 56 Magnetic Resonance Spectroscopy 54 Goserelin 54 Androgen Antagonists 51 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47 apalutamide 44 abiraterone 34 Radiosurgery 31 Specimen Handling 30 gallium 68 PSMA-11 29 Gonadotropin-Releasing Hormone 29 cabazitaxel 28 Carboplatin 27 darolutamide 25 Estramustine 24 luprolide acetate gel depot 23 relugolix 22 Metformin 22 Triptorelin Pamoate 20 sipuleucel-T 19 radium Ra 223 dichloride 19 Radiation 19 pembrolizumab 18 deltacortene 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Neoplasms × Tablets × Clear all

NCT05265988 2024-07-31

MERIDIAN

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡